Geron GERN
NASDAQ GERN
$1.38 -0.02 (-1.78%)
As of: Sep 10, 2026 · 3:59 PM EDT

Geron (GERN) Net Shares Issued and Repurchased (2012 - 2024)

Geron's (GERN) quarterly Net Shares Issued and Repurchased came in at $29.6 million in Q4 2024, up 41.95% year-over-year from $20.9 million in Q1 2024, and up 41.95% quarter-over-quarter from $20.9 million in Q4 2023.

Analysis

Geron (GERN) Net Shares Issued and Repurchased (2012 - 2024) Analysis & Trends

Geron has disclosed Net Shares Issued and Repurchased across 13 years of filings, most recently posting $29.6 million for Q4 2024.

  • In Q4 2024, Net Shares Issued and Repurchased rose 41.95% year-over-year to $29.6 million; the TTM figure through Dec 2024 stood at $29.6 million (up 41.95% YoY), while the FY2024 annual figure was $29.6 million, up 41.95% from the prior year.
  • Net Shares Issued and Repurchased came in at $29.6 million for Q4 2024 at Geron, up from $20.9 million in the prior quarter.
  • In the past five years, Net Shares Issued and Repurchased ranged from a high of $29.6 million in Q4 2024 to a low of $6.5 million in Q4 2020.
  • Average Net Shares Issued and Repurchased over 5 years is $17.3 million, with a median of $19.7 million recorded in 2022.
  • Year-over-year, Net Shares Issued and Repurchased tumbled 44.34% in 2020 and soared 106.52% in 2022.
  • Over 5 years, Net Shares Issued and Repurchased stood at $6.5 million in 2020, then jumped by 46.39% to $9.6 million in 2021, then jumped by 106.52% to $19.7 million in 2022, then climbed by 5.61% to $20.9 million in 2023, then surged by 41.95% to $29.6 million in 2024.
  • Per Business Quant data, the three most recent Net Shares Issued and Repurchased figures were $29.6 million in Q4 2024, $20.9 million in Q4 2023, and $19.7 million in Q4 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Shares Issued and Repurchased (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn -
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn -
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn -
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn -
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn -
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn -
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn -
10 Geron 914.60 Mn 613.75 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 29.60 Mn
Dec 31, 2023 20.86 Mn
Dec 31, 2022 19.75 Mn
Dec 31, 2021 9.56 Mn
Dec 31, 2020 6.53 Mn
Dec 31, 2019 11.74 Mn
Mar 31, 2019 1.98 Mn
Dec 31, 2018 9.27 Mn
Dec 31, 2017 3.48 Mn
Dec 31, 2016 2.83 Mn
Dec 31, 2015 2.88 Mn
Dec 31, 2014 5.66 Mn
Dec 31, 2013 6.64 Mn
Dec 31, 2012 7.53 Mn